Jefferies Starts Valeant Pharmaceuticals (VRX) at Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Jefferies Starts Valeant Pharmaceuticals (VRX) at Buy

TD Securities Upgrades Valeant Pharmaceuticals (VRX) to Buy

April 23, 2014 7:23 AM EDT

TD Securities upgraded Valeant Pharmaceuticals (NYSE: VRX) from Hold to Buy with a price target of $160.00 (from $145.00). The change follows news it is teaming with Bill Ackman to acquire Allergan.

Analyst Lennox Gibbs said, "The proposed transaction could substantially... More